Pharmaceutical Industry Corruption Is Structural, Systemic, and Profitable, New Review Finds
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Mon, 14 September 2026
What it is about
John BraitwaiteGlaxosmith KlineSmithkline BeechamReckitt Benckisser IndiviorEli LillyExchange CommissionSuffolk UniversityOrganisation For EconomicGlaxosmithklinePfizerJohnson JohnsonBristol Myers SquibbNovartisPublic Citizen Health Research GroupBoston, Massachusetts, United States
Who published it, and when
How it spread - 1 original report
Mon, 14 September 2026
1 report- madinamerica.com10:00first to report
A new empirical review published in the Journal of Law, Medicine & Ethics reports that pharmaceutical industry corruption is a structural, Legal scholar Marc A. Rodwin argues that ending widespread industry misconduct requires a complete structural separation between drug money and medical decision-makers.